Reply to the letter to the editor 'treating breast cancer with trabectedin: a new arsenal' by L. Malik

Ann Oncol. 2014 Oct;25(10):2095. doi: 10.1093/annonc/mdu263. Epub 2014 Jul 23.

Authors

S Delaloge¹, M Cullell-Young²

Affiliations

¹ Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. Electronic address: [email protected].
² Pharma Mar SA, Barcelona, Spain.

PMID: 25057170
DOI: 10.1093/annonc/mdu263

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents, Alkylating / therapeutic use*
Breast Neoplasms / drug therapy*
Dioxoles / therapeutic use*
Female
Humans
Tetrahydroisoquinolines / therapeutic use*

Substances

Antineoplastic Agents, Alkylating
Dioxoles
Tetrahydroisoquinolines